Streptozotocin-induced diabetes selectively alters the potency of analgesia produced by μ-opioid agonists, but not by δ- and κ-opioid agonists
- 1 February 1992
- journal article
- research article
- Published by Elsevier in Brain Research
- Vol. 571 (2) , 199-203
- https://doi.org/10.1016/0006-8993(92)90655-s
Abstract
No abstract availableKeywords
This publication has 16 references indexed in Scilit:
- Streptozotocin-induced diabetes in mice reduces the nociceptive threshold, as recognized after application of noxious mechanical stimuli but not of thermal stimuliPharmacology Biochemistry and Behavior, 1991
- Development of supersensitivity to substance P in the spinal cord of the streptozotocin-induced diabetic ratsPharmacology Biochemistry and Behavior, 1990
- Anatomy of CNS opioid receptorsTrends in Neurosciences, 1988
- The analgesic defect of C57BL/6J-bgJ/bgJ (beige-J; Chediak-Higashi syndrome) mice transmitted by adoptive transfer of spleen cells to normal littermatesLife Sciences, 1988
- C57BL/6J-bg J (beige) mice: Differential sensitivity in the tail flick test to centrally administered MU- and delta-opioid receptor agonistsLife Sciences, 1987
- Multiple opiate binding sites in rat spinal cordLife Sciences, 1982
- Multiple opiate receptor sites on primary afferent fibresNature, 1980
- Differential Regulation by Guanine Nucleotides of Opiate Agonist and Antagonist Receptor InteractionsJournal of Neurochemistry, 1980
- Reduced sensitivity to L-tryptophan and p-chloro amphetamine in streptozotocin-diabetic ratsJournal of Pharmacy and Pharmacology, 1978
- Identification of novel high affinity opiate receptor binding in rat brainNature, 1975